143 related articles for article (PubMed ID: 22272707)
1. RNA-based markers as prognostic factors in chronic lymphocytic leukemia.
Sevov M; Rosenquist R; Mansouri L
Expert Rev Hematol; 2012 Feb; 5(1):69-79. PubMed ID: 22272707
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase is differentially expressed in prognostic subsets of chronic lymphocytic leukemia but displays invariably low catalytical activity.
Mansouri M; Sevov M; Fahlgren E; Tobin G; Jondal M; Osorio L; Roos G; Olivecrona G; Rosenquist R
Leuk Res; 2010 Mar; 34(3):301-6. PubMed ID: 19709746
[TBL] [Abstract][Full Text] [Related]
4. Lipoprotein lipase in chronic lymphocytic leukaemia - strong biomarker with lack of functional significance.
Porpaczy E; Tauber S; Bilban M; Kostner G; Gruber M; Eder S; Heintel D; Le T; Fleiss K; Skrabs C; Shehata M; Jäger U; Vanura K
Leuk Res; 2013 Jun; 37(6):631-6. PubMed ID: 23478142
[TBL] [Abstract][Full Text] [Related]
5. Prognostic markers in chronic lymphocytic leukemia: a comprehensive review.
Van Bockstaele F; Verhasselt B; Philippé J
Blood Rev; 2009 Jan; 23(1):25-47. PubMed ID: 18599169
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein lipase expression in unmutated CLL patients is the consequence of a demethylation process induced by the microenvironment.
Moreno P; Abreu C; Borge M; Palacios F; Morande P; Pegazzano M; Bianchi S; Landoni AI; Agrelo R; Giordano M; Dighiero G; Gamberale R; Oppezzo P
Leukemia; 2013 Mar; 27(3):721-5. PubMed ID: 22828442
[No Abstract] [Full Text] [Related]
7. Risk stratification in chronic lymphocytic leukemia.
Seiler T; Döhner H; Stilgenbauer S
Semin Oncol; 2006 Apr; 33(2):186-94. PubMed ID: 16616065
[TBL] [Abstract][Full Text] [Related]
8. Identification of progression markers in B-CLL by gene expression profiling.
Fält S; Merup M; Gahrton G; Lambert B; Wennborg A
Exp Hematol; 2005 Aug; 33(8):883-93. PubMed ID: 16038780
[TBL] [Abstract][Full Text] [Related]
9. Analysis of CD38 and ZAP70 mRNA expression among cytogenetic subgroups of Iranian chronic-lymphocytic-leukemia patients.
Teimori H; Akbari MT; Hamid M; Forouzandeh M; Bibordi E
Genet Mol Res; 2011 Oct; 10(4):2415-23. PubMed ID: 22002134
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein lipase SNPs rs13702 and rs301 correlate with clinical outcome in chronic lymphocytic leukemia patients.
Rombout A; Stamatopoulos B; Lagneaux L; Lust S; Offner F; Naessens E; Vanderstraeten H; Verhasselt B; Philippé J
PLoS One; 2015; 10(3):e0121526. PubMed ID: 25811490
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic factors in chronic lymphocytic leukaemia: contribution of recent biological markers].
Evrard S; Gaussem P; Helley D; Darnige L
Ann Biol Clin (Paris); 2005; 63(6):589-97. PubMed ID: 16330377
[TBL] [Abstract][Full Text] [Related]
13. The role of prognostic factors in assessing 'high-risk' subgroups of patients with chronic lymphocytic leukemia.
Kay NE; O'Brien SM; Pettitt AR; Stilgenbauer S
Leukemia; 2007 Sep; 21(9):1885-91. PubMed ID: 17568813
[TBL] [Abstract][Full Text] [Related]
14. Impaired up-regulation of polo-like kinase 2 in B-cell chronic lymphocytic leukaemia lymphocytes resistant to fludarabine and 2-chlorodeoxyadenosine: a potential marker of defective damage response.
de Viron E; Knoops L; Connerotte T; Smal C; Michaux L; Saussoy P; Vannuffel P; Beert E; Vekemans MC; Hermans C; Bontemps F; Van Den Neste E
Br J Haematol; 2009 Dec; 147(5):641-52. PubMed ID: 19764992
[TBL] [Abstract][Full Text] [Related]
15. Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL).
Zenz T; Fröhling S; Mertens D; Döhner H; Stilgenbauer S
Best Pract Res Clin Haematol; 2010 Mar; 23(1):71-84. PubMed ID: 20620972
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression induction by TRAIL in B chronic lymphocytic leukemia (B-CLL) cells showing high versus low levels of Zap-70.
Secchiero P; di Iasio MG; Gonelli A; Barbarotto E; Melloni E; Tiribelli M; Chiaruttini C; Zauli G
J Cell Physiol; 2007 Oct; 213(1):229-36. PubMed ID: 17476690
[TBL] [Abstract][Full Text] [Related]
17. Toward a comprehensive prognostic scoring system in chronic lymphocytic leukemia based on a combination of genetic parameters.
Haferlach C; Dicker F; Weiss T; Schnittger S; Beck C; Grote-Metke A; Oruzio D; Kern W; Haferlach T
Genes Chromosomes Cancer; 2010 Sep; 49(9):851-9. PubMed ID: 20552631
[TBL] [Abstract][Full Text] [Related]
18. PRAME mRNA levels in cases with chronic leukemia: Clinical importance and review of the literature.
Paydas S; Tanriverdi K; Yavuz S; Seydaoglu G
Leuk Res; 2007 Mar; 31(3):365-9. PubMed ID: 16914202
[TBL] [Abstract][Full Text] [Related]
19. UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?
Bhoi S; Baliakas P; Cortese D; Mattsson M; Engvall M; Smedby KE; Juliusson G; Sutton LA; Mansouri L
Haematologica; 2016 Feb; 101(2):e63-5. PubMed ID: 26589911
[No Abstract] [Full Text] [Related]
20. A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples.
Pekova S; Mazal O; Cmejla R; Hardekopf DW; Plachy R; Zejskova L; Haugvicova R; Jancuskova T; Karas M; Koza V; Smolej L; Bezdickova L; Kozak T
Leuk Res; 2011 Jul; 35(7):889-98. PubMed ID: 21232794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
